Answers are grounded in this paper and cite their sources.
Demonstrates prolonged lifespan in aged mice with psilocybin treatment, suggesting therapeutic potential for aging.
Psilocybin, the naturally occurring psychedelic compound produced by hallucinogenic mushrooms, has received attention due to considerable clinical evidence for its therapeutic potential to treat various psychiatric and neurodegenerative indications. However, the underlying molecular mechanisms remain enigmatic, and few studies have explored its systemic impacts. We provide the first experimental evidence that psilocin (the active metabolite of psilocybin) treatment extends cellular lifespan and psilocybin treatment promotes increased longevity in aged mice, suggesting that psilocybin may be a potent geroprotective agent.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: